PSA levels after treatment may not be reliable predictor of survival for patients with prostate cancer

by University of California, Los AngelesCredit: Unsplash/CC0 Public DomainA UCLA-led study has found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising pr

Updated on: February 18,2024

PSA levels after treatment may not be reliable predictor of survival for patients with prostate cancer

by University of California, Los AngelesCredit: Unsplash/CC0 Public DomainA UCLA-led study has found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising pr

Updated on:February 18,2024

Aggressive breast cancers store large amounts of energy, which enables it to spread: study

by University of MichiganSofia Merajver, M.D., Ph.D. Credit: University of Michigan Rogel Cancer CenterCancer cells—especially the more aggressive ones—seem to have an ability to change. It's

Updated on: June 28,2024

Aggressive breast cancers store large amounts of energy, which enables it to spread: study

by University of MichiganSofia Merajver, M.D., Ph.D. Credit: University of Michigan Rogel Cancer CenterCancer cells—especially the more aggressive ones—seem to have an ability to change. It's

Updated on:June 28,2024

Modeling the use of beta radiation in cancer treatment

bySpringerIllustration of beta decay proceeding against the backdrop of a Monte Carlo simulation. Credit: Robert LeaTreating superficial skin tumors especially when they are located above cartil

Updated on: January 02,2024

Modeling the use of beta radiation in cancer treatment

bySpringerIllustration of beta decay proceeding against the backdrop of a Monte Carlo simulation. Credit: Robert LeaTreating superficial skin tumors especially when they are located above cartil

Updated on:January 02,2024

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

Updated on: January 28,2024

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

Updated on:January 28,2024

Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

byUppsala UniversityA graphical summary illustrates the strategy used to identify CYP2D6 as a target for collateral lethality, which is driven by the widespread occurrence of loss of heterozygos

Updated on: December 01,2024

Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

byUppsala UniversityA graphical summary illustrates the strategy used to identify CYP2D6 as a target for collateral lethality, which is driven by the widespread occurrence of loss of heterozygos

Updated on:December 01,2024

Can what works to treat cancer work for diabetes?

by Jess Berthold,University of California, San FranciscoCredit: CC0 Public DomainTo live with type 1 diabetes is to be ruled by relentless routine. Food must be carefully monitored, and the only

Updated on: January 30,2024

Can what works to treat cancer work for diabetes?

by Jess Berthold,University of California, San FranciscoCredit: CC0 Public DomainTo live with type 1 diabetes is to be ruled by relentless routine. Food must be carefully monitored, and the only

Updated on:January 30,2024

Interpreting and Commenting on the Role of Oct4 in M2 Macrophage Polarization and Tumor Progression in Lung Cancer

Updated on: October 01,2024

Interpreting and Commenting on the Role of Oct4 in M2 Macrophage Polarization and Tumor Progression in Lung Cancer

Updated on:October 01,2024

Trial results show PARP inhibitor benefit in 'BRCA-like' breast cancer

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly extend progression-free surviva

Updated on: January 04,2024

Trial results show PARP inhibitor benefit in 'BRCA-like' breast cancer

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly extend progression-free surviva

Updated on:January 04,2024

Is the pap smear on the way out?

by Steven Reinberg, Healthday Reporter(HealthDay)—The Pap test, used for over 50 years to spot the early signs of cervical cancer, may soon become a thing of the past, new research suggests.Its replac

Updated on: April 01,2024

Is the pap smear on the way out?

by Steven Reinberg, Healthday Reporter(HealthDay)—The Pap test, used for over 50 years to spot the early signs of cervical cancer, may soon become a thing of the past, new research suggests.Its replac

Updated on:April 01,2024

A new strategy to attack aggressive brain cancer shrank tumors in two early tests

by Lauran NeergaardThis combination of MRI scan images provided by theNew England Journal of Medicinein March 2024 shows the progress of a glioblastoma patient who received CAR-T therapy w

Updated on: March 20,2024

A new strategy to attack aggressive brain cancer shrank tumors in two early tests

by Lauran NeergaardThis combination of MRI scan images provided by theNew England Journal of Medicinein March 2024 shows the progress of a glioblastoma patient who received CAR-T therapy w

Updated on:March 20,2024

Team pioneers cancer treatment that targets bone metastases while sparing bone

by University of California, IrvineCredit: CC0 Public DomainUniversity of California, Irvine researchers have developed and tested on mice a therapeutic treatment that uses engineered stem cells

Updated on: May 27,2024

Team pioneers cancer treatment that targets bone metastases while sparing bone

by University of California, IrvineCredit: CC0 Public DomainUniversity of California, Irvine researchers have developed and tested on mice a therapeutic treatment that uses engineered stem cells

Updated on:May 27,2024

New study generates predictive model to help identify melanoma patients best eligible for sentinel lymph node biopsy

by Sutter HealthDiscriminating Among Sentinel Lymph Node Biopsy Outcomes Using Various Prognostic Methodologies Receiver operating characteristic curve plots of sentinel lymph node biopsy outcome disc

Updated on: January 12,2024

New study generates predictive model to help identify melanoma patients best eligible for sentinel lymph node biopsy

by Sutter HealthDiscriminating Among Sentinel Lymph Node Biopsy Outcomes Using Various Prognostic Methodologies Receiver operating characteristic curve plots of sentinel lymph node biopsy outcome disc

Updated on:January 12,2024